1000027-12-2

Basic information

• Product Name: N,N-dibenzyl-3-methoxypiperidin-4-amine
• Synonyms: N,N-dibenzyl-3-methoxypiperidin-4-amine
• CAS NO: 1000027-12-2
• Molecular Weight: 310.439
• Mol File: 1000027-12-2.mol

Chemical Properties

• CAS DataBase Reference: N,N-dibenzyl-3-methoxypiperidin-4-amine(CAS DataBase Reference)
• NIST Chemistry Reference: N,N-dibenzyl-3-methoxypiperidin-4-amine(1000027-12-2)
• EPA Substance Registry System: N,N-dibenzyl-3-methoxypiperidin-4-amine(1000027-12-2)

Safety Data

• Hazardous Substances Data: 1000027-12-2(Hazardous Substances Data)

Upstream product

• 1000027-11-1 ethyl 4-(dibenzylamino)-3-methoxypiperidine-1-carboxylate 
• 128225-42-3 ethyl 4-amino-3-methoxy-1-piperidinecarboxylate 
• 83863-73-4 (-)-ethyl 3,4,4-trimethoxy-1-piperidinecarboxylate 
• 83863-72-3 (-)-ethyl 3-methoxy-4-oxo-1-piperidine-carboxylate 
• 29976-53-2 N-ethoxycarbonyl-4-piperidone 
• 103-49-1 dibenzylamine 
• 83898-43-5 ethyl 3-hydroxy-4,4-dimethoxy-1-piperidinecarboxylate 

Downstream Products

• 860169-74-0 (3S,4R)-N,N-dibenzyl-3-methoxypiperidin-4-amine 
• 860174-12-5 Naronapride 
• 860169-77-3 ethyl 6-((3S,4R)-4-(dibenzylamino)-3-methoxypiperidin-1-yl)hexanoate 
• 860169-80-8 (R)-quinuclidin-3-yl 6-((3S,4R)-4-(dibenzylamino)-3-methoxypiperidin-1-yl)hexanoate 

Relevant articles and documents

LUMINALLY-ACTING N-(PIPERIDIN-4-YL)BENZAMIDE DERIVATIVES

Disclosed are compounds of Formula 1, and pharmaceutically acceptable salts thereof, wherein m, R1, R2, R3, R4, R5, R6, X1, X2, X3 and X4 are defined in the specification. This disclosure also relates to materials and methods for preparing compounds of Formula 1, to pharmaceutical compositions which contain them, and to their use for treating diseases, disorders, and conditions associated with the 5-HT4 receptor.

PIPERIDINE DERIVATIVES FOR THE TREATMENT OF GASTROINTESTINAL AND CNS DISORDERS

The subject invention provides stereoisomeric compounds of formula (X): wherein the variables are as defined herein, and compositions for the safe and effective treatment of various gastrointestinal disorders including, but not limited to, gastroparesis,

SYNTHETIC METHODS AND INTERMEDIATES FOR STEREOISOMERIC COMPOUNDS USEFUL FOR THE TREATMENT OF GASTROINTESTINAL AND CENTRAL NERVOUS SYSTEM DISORDERS

The subject invention provides methods and/or processes for making stereoisomeric compounds of formula (X): wherein the variables are as defined herein, and compositions for the safe and effective treatment of various gastrointestinal disorders including,

STEREOISOMERIC PYRIDYL AND PYRIDONYL COMPOUNDS AND METHODS FOR THE TREATMENT OF GASTROINTESTINAL AND CENTRAL NERVOUS SYSTEM DISORDERS

The subject invention provides stereoisomeric compounds of formulae Xa and Xb; wherein the variables are as defined herein, and compositions for the safe and effective treatment of various gastrointestinal disorders including, but not limited to, gastropa

STEREOISOMERIC COMPOUNDS AND METHODS FOR THE TREATMENT OF GASTROINTESTINAL AND CENTRAL NERVOUS SYSTEM DISORDERS

The subject invention provides stereoisomeric compounds of formula (X): wherein the variables are as defined herein, and compositions for the safe and effective treatment of various gastrointestinal disorders including, but not limited to, gastroparesis,